ライフサイエンスコーパス: TTE

1 TTE achieved a higher rate of R0 resections (86.2% vs 73

2 TTE and CMR performed on the same day in 57 prospectivel

3 TTE and TEE classified the majority (82% and 85%, respec

4 TTE and TEE were performed in 105 consecutive patients w

5 TTE cells were localized in the isthmus adjacent to doub

6 TTE cells were localized to the isthmus, above and disti

7 TTE indications (appropriate [A], may be appropriate [M]

8 TTE overestimates LVM and MWT and has lower reproducibil

9 TTE revealed anatomic abnormalities in 33 patients, but

10 TTE RVol(AR) was calculated as Doppler left ventricular

11 TTE shortening corresponded to a reduction in inotropic

12 TTE studies were reviewed in 58 patients (35 with PD and

13 TTE was either beneficial in pN2 disease for cT3 AC + SC

14 TTE was superior in terms of higher positive likelihood

15 ysicians who ordered, on average, at least 1 TTE per month, there was a significantly lower proportio

16 romethanesulfonyl)imide (LiTFSI) salt, 12C4, TTE and H(2)O solvents (labelled LiTFSI-12C4@TTE/H(2)O)

17 TTE and H(2)O solvents (labelled LiTFSI-12C4@TTE/H(2)O) demonstrates low impedance (2.7 Omega cm(-)(2

18 Doppler (TMD), against two-dimensional (2D) TTE contrast study and the gold standard, of transesopha

19 2D-TTE can be used to help determine the need for hospital

20 2D-TTE increased specificity and sensitivity of detecting c

21 2D-TTE was characterized by sensitivity of 85.86%, specific

22 2D-TTE was obtained using the HI vision Avius ultrasound un

23 was significantly different between the 4 2D-TTE views (3.85+/-0.58, 3.87+/-0.61, 4.02+/-0.69, and 3.

24 In contrast, 2D-TTE measurements were significantly smaller and only mod

25 mensional transthoracic echocardiography (2D-TTE) in 282 patients in 4 different views (parasternal l

26 mensional transthoracic echocardiography (2D-TTE) to determine causes of acute chest pain in patients

27 Measurements of the TAD using 2D-TTE in A4C were highly feasible and reproducible and des

28 ardiology clinicians ordered 10 654 and 3761 TTEs during the baseline and intervention periods, respe

29 A total of 71 660 TTEs with 1 203 980 colour Doppler videos were included.

30 A total of 61 689 TTEs were split into train (n=43 811), validation (n=889

31 4 to April 2016, the authors assessed 14,697 TTEs for appropriateness, of which 99% were classifiable

32 , AI-derived ATTR-CM probabilities from 7352 TTEs and 32 205 ECGs diverged as early as 3 years before

33 Our study cohort was 55 773 TTEs corresponding to 37 843 intervals ordered by 635 pr

34 with an additional external test set of 8208 TTEs.

35 A total of 341 (72.9%) TTE and 127 (27.1%) THE were performed.

36 Among all beneficiaries who received a TTE (N=4 033 844), adjusting for age, sex, and 27 comorb

37 Among US Medicare beneficiaries receiving a TTE, International Classification of Diseases, Tenth Rev

38 cal probability, 12 had technically adequate TTE studies; 10 of these (83%) were classified as either

39 METHODS AND We obtained records of all TTEs from 2001 to 2016 completed at a large echocardiogr

40 Among TTE normal subjects, 3790 subjects (2432 women, 1358 men

41 On multivariable analysis, TTE remained an independent factor for survival.

42 Comparison of PC-CMR and TTE aortic peak velocities and mean gradients resulted i

43 LV DD was classified by CMR and TTE following 2016 guidelines.

44 Correlation between multidetector CT and TTE for global function (r = 0.68) and RWM (kappa = 0.79

45 ts at 3 tertiary centers undergoing FLOT and TTE.

46 bnormalities, and with myocardial injury and TTE abnormalities.

47 derwent symptom-prompted ammonia N13 PET and TTE within 90 days.

48 odel simulations were tuned to match RHC and TTE pressure, volume, and cardiac output measurements in

49 ne of three groups according to LV shape and TTE-derived mitral filling parameters.

50 blinded to the indication for the study and TTE results but not to the device source interpreted the

51 ations between the proportion of appropriate TTEs and published year (p = 0.36) for 2007 AUC, there w

52 nt increase in the proportion of appropriate TTEs in the intervention vs control group (1054 [77.6%]

53 scribed the percentage of rarely appropriate TTEs as well as the appropriate use criteria rationale f

54 ion reduced the number of rarely appropriate TTEs ordered by attending academic cardiologists.

55 ention, the proportion of rarely appropriate TTEs was significantly lower in the intervention vs cont

56 y outcome was the rate of rarely appropriate TTEs.

57 ould reduce the number of rarely appropriate TTEs.

58 (LVMI) and MWT were significantly higher at TTE compared with MRI (105 g/m(2) +/- 48 vs 78 g/m(2) +/

59 TTE)=0.87+/-0.44 cm(2)) and 21 controls (AVA(TTE)=2.96+/-0.59 cm(2)) who had TTE and PC-CMR of aortic

60 We studied 53 AVS patients (AVA(TTE)=0.87+/-0.44 cm(2)) and 21 controls (AVA(TTE)=2.96+/

61 CMR3)), AVA(CMR1) values were lower than AVA(TTE) especially for higher AVA (mean bias=-0.45+/-0.52 c

62 There was concordance between TTE and TEE in 83% of all cases.

63 Although good agreement was found between TTE and continuity equation-based CMR-AVA (r>0.94 and me

64 The mean interval between TTEs was 12.4 months, 17.0 months, 18.3 months, and 17.4

65 e outcome variable was time interval between TTEs.

66 FLOT and en bloc TTE was safe, with no discernible impact on operative co

67 criteria and separately on the basis of both TTE and TEE findings.

68 ombus vs. mismatch) was identified in 10% by TTE and 49% by TEE (p < 0.001).

69 kelihood category by echocardiography (15 by TTE and 12 by TEE).

70 mechanism was correctly identified in 63% by TTE and in 81% by TEE (p = 0.18).

71 s a useful tool for identifying severe AS by TTE, with sex-specific thresholds for severe AS identifi

72 y of PC-CMR to detect severe AVS, defined by TTE, provided the best results for continuity equation-b

73 se, which can be prospectively identified by TTE.

74 9/10 patients and was reliably identified by TTE; the other patient had an intramyocardial course of

75 ted well with resting GLS strain obtained by TTE, and the measure is reproducible.

76 e diagnostic and prognostic role provided by TTE images, TEE provides unique advantages including the

77 Although RVol(MR) is similar by TTE and CMR, variability in measured RVol by both approa

78 Data from 143 patients treated by TTE by one author (1989-1999) were entered into a comput

79 e are transcriptionally induced at 12 hpi by TTEs.

80 servatively identified as being modulated by TTEs within 12 h post-inoculation (hpi), 20% of which re

81 ents with gastroesophageal junction cancers, TTE can be performed with a low death rate (2.1%), a low

82 Investigators classifying TTEs were blinded to participant groupings.

83 lt, the total cost of a trial using complete TTE was greater than CMR, which was greater than limited

84 l DL system was developed to intake complete TTEs, identify color MR Doppler videos, and determine MR

85 studies were performed in three conditions--TTE TMD, TTE 2D and TEE.

86 Contrast TTE was conclusive in 324 of 361 patients and showed PFO

87 ions, a resting PFO was detected by contrast TTE in three cases.

88 Because of inconclusive contrast TTE or MRI, 46 patients were excluded from analysis.

89 of 4042 adult angiograms with corresponding TTE LVEF from 3679 UCSF patients were included in the an

90 intervention to raise awareness of critical TTE findings and improve the quality of care for patient

91 Current TTE methods are relatively insensitive in PFO detection

92 trategy 3: cost $2,774, QALY 8.49) dominates TTE/TEE-guided cardioversion (strategy 2: cost $3,106, Q

93 Doppler TTE is the primary means to diagnose AVR obstruction; he

94 ructure and function during complete Doppler TTE studies.

95 s, of whom 15 596 (15%) had a normal Doppler TTE study.

96 Preoperative Doppler TTE was performed in all cases.

97 At early TTE, PPR was not observed (n = 56) or remained unchanged

98 llow-up transthoracic echocardiograms (early TTEs) were obtained within six weeks of surgery in 99.0%

99 A limited transthoracic echocardiogram (TTE) can be an appropriate, lower-cost substitute for a

100 tation (MR) in transthoracic echocardiogram (TTE) due to relative contraindications to transesophagea

101 ) have defined transthoracic echocardiogram (TTE) indications for which there is a clear lack of bene

102 VSD on initial transthoracic echocardiogram (TTE) that resolved during donor management.

103 had ordered a transthoracic echocardiogram (TTE) with findings potentially indicative of severe AS w

104 andard resting transthoracic echocardiogram (TTE) with global longitudinal strain (GLS) analysis with

105 angiogram and transthoracic echocardiogram (TTE) within 3 months before or 1 month after the angiogr

106 ic tests, and transthoracic echocardiograms (TTEs) performed: (1) within 48 hours after brain death w

107 d undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during their in

108 pared a new transthoracic echocardiographic (TTE) method for detection of right to left bubble passag

109 seen on 216 transthoracic echocardiographic (TTE) studies, and their relationship to postoperative ou

110 Transthoracic echocardiographic (TTE) surveillance of patients with mitral regurgitation

111 ver, transthoracic Doppler echocardiography (TTE) remains inconclusive in a significant number of pat

112 iateness for transthoracic echocardiography (TTE) (80% [95% confidence interval (CI): 0.75 to 0.84] v

113 a systematic transthoracic echocardiography (TTE) and a 12-month course of doxycycline and hydroxychl

114 Both transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) imaging allow

115 tic contrast transthoracic echocardiography (TTE) and cerebral magnetic resonance imaging (MRI) withi

116 (AI)-enabled transthoracic echocardiography (TTE) and electrocardiography (ECG) may provide a scalabl

117 ression with transthoracic echocardiography (TTE) and magnetic resonance imaging (MRI).

118 ther Doppler transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) have red

119 nal therapy--transthoracic echocardiography (TTE) and warfarin therapy for 1 month before cardioversi

120 ith standard transthoracic echocardiography (TTE) are not available.

121 testing with transthoracic echocardiography (TTE) are unable to undergo testing owing to poor acousti

122 f performing transthoracic echocardiography (TTE) as part of the clinical assessment of patients awai

123 ompared with transthoracic echocardiography (TTE) by using multidetector CT.

124 Focused transthoracic echocardiography (TTE) during cardiac arrest resuscitation can enable the

125 clinical and transthoracic echocardiography (TTE) features.

126 ion, resting transthoracic echocardiography (TTE) for assessment of myocardial structure and function

127 d by Doppler transthoracic echocardiography (TTE) from a clinical echocardiographic database of 102 8

128 c outpatient transthoracic echocardiography (TTE) have not yet been evaluated for clinical applicabil

129 cases (72%), transthoracic echocardiography (TTE) identified a valvular lesion of acute Q fever endoc

130 e (CMR) over transthoracic echocardiography (TTE) in ischemic cardiomyopathy and nonischemic dilated

131 We performed transthoracic echocardiography (TTE) in patients with stable COPD from the COSYCONET (CO

132 tic value of transthoracic echocardiography (TTE) in the detection of PFO in patients with cryptogeni

133 on (RHC) and transthoracic echocardiography (TTE) of heart failure (HF) patients using a closed-loop

134 n to improve transthoracic echocardiography (TTE) ordering practices of physicians in training.

135 hey received transthoracic echocardiography (TTE) to detect or exclude cardiac findings with relevanc

136 imaging and transthoracic echocardiography (TTE) were performed in 18 individuals.

137 ostoperative transthoracic echocardiography (TTE) within 6 weeks of surgery.

138 arditis, (1) transthoracic echocardiography (TTE) would be most valuable in patients with an intermed

139 ter baseline transthoracic echocardiography (TTE), adult ICR mice were injected i.p. with vehicle (10

140 ss of repeat transthoracic echocardiography (TTE), and (c) whether thyroid status and therapy affecte

141 PFO include transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and transcr

142 pectively by transthoracic echocardiography (TTE).

143 pretation of transthoracic echocardiography (TTE).

144 e food web: the trophic transfer efficiency (TTE) and the biomass residence time (BRT) in the food we

145 ch can be avoided by target trial emulation (TTE).

146 e summed to represent total THC equivalents (TTE) in urine.

147 OT with en-bloc transthoracic esophagectomy (TTE) are limited.

148 Further discussions are needed to establish TTE approaches to estimating 4 effects of vaccination, u

149 vation from TFF2 mRNA transcript-expressing (TTE) cells.

150 Extended TTE achieved a higher rate of R0 resections, a higher ly

151 Time to extubation (TTE) was the primary outcome.

152 irty-day mortality rate was 6.6% (8/121) for TTE and 7.4% (9/121) for THE (P = 0.600).

153 ues (LR+ = 106.61, 95% CI = 15.09-753.30 for TTE vs LR+ = 12.62, 95% CI = 6.52-24.43 for TCD; p = 0.0

154 ) for CMR and -9 mL (95% CI, -53 to -36) for TTE.

155 face area and -10 mL (95% CI, -76 to 56) for TTE volume flow at 2 sites.

156 nce with standardized grades established for TTE.

157 Although the point estimate for TTE levels was higher among children with detectable uri

158 ft from cardiologist offices to the HOPD for TTE (office: -23%; HOPD: +107%) and SE (office: -44%; HO

159 opriate use in imaging show improvements for TTE and CTA but not for stress imaging and TEE.

160 tantial variation in follow-up intervals for TTE assessment of mitral regurgitation, despite risk-adj

161 -96.1%), whereas the respective measures for TTE were 45.1% (95% CI = 30.8-60.3%) and 99.6% (95% CI =

162 ppler is a sensitive and specific method for TTE PFO detection that allows quantification of right to

163 At the time of referral for TTE, ultrasonographers acquired PME images first in 5 mi

164 Overly frequent TTEs can impair patient access and reduce value in care

165 Surface mucus cells were not derived from TTE cells and the progeny of the TTE lineage did not sur

166 ostic importance of information derived from TTE on long-term all-cause mortality in a selected group

167 ppropriate, lower-cost substitute for a full TTE.

168 In the matched groups, TTE was beneficial for pT3 SCC (P = 0.004), pT3 AC (P =

169 n age of 16 +/- 2.8 years; the other six had TTE for suspected congenital heart disease/musculoskelet

170 ontrols (AVA(TTE)=2.96+/-0.59 cm(2)) who had TTE and PC-CMR of aortic valve and left ventricular outf

171 dows that prevented adequate second harmonic TTE imaging were consecutively referred for MRI to diagn

172 ions and has incremental diagnostic value if TTE is inconclusive.

173 This strategy may be feasible to improve TTE utilization among cardiologists, and this type of in

174 ptual framework to address selection bias in TTE studies, tailored toward time-to-event end points, a

175 ptual framework to address selection bias in TTE studies, tailored towards time-to-event endpoints, a

176 rovider factors contributing to variation in TTE utilization and hypothesized that variation was attr

177 ed some DNA sieving ability at 0.5% (w/w) in TTE (50 mM Tris, 50 mM TAPS, 2 mM EDTA, pH 8.4) buffer.

178 TE and 21% of patients with an indeterminate TTE.

179 CI, 1.69-4.57]; P<0.001), and when the index TTE was performed within the inpatient setting (OR, 2.49

180 for 1 month before cardioversion; 2) initial TTE, followed by TEE and early cardioversion if no throm

181 An initial TTE was interpreted for 3794 of the 4333 potential donor

182 Among those donors with an initial TTE, LV dysfunction was associated with younger age, und

183 strategy should consider eliminating initial TTE and carefully assess both the thromboembolic and hem

184 ejection fraction [LVEF] </=40%) on initial TTE that resolved (LVEF >/=50%) during donor management

185 ith normal LVEF (LVEF >/=55%) on the initial TTE for recipient mortality, cardiac allograft vasculopa

186 At late TTE, four patients were found to have progression of the

187 eks of surgery in 99.0% of patients and late TTEs (mean 2.1 years) in 54.3%.

188 sal response, virulence factors (most likely TTEs) targeted genes involved in phenylpropanoid biosynt

189 ter than CMR, which was greater than limited TTE.

190 trials than echocardiography, unless limited TTE is used.

191 ding clinical guidance on the use of limited TTEs at the point of care increased the selection of thi

192 Odds of an abnormal finding in an A or M TTE were 6 times that of R (95% confidence interval [CI]

193 The detected and projected changes in mean TTE and BRT will undermine food web functioning.

194 arth system models, we project that the mean TTE in coastal waters would decrease from 7.7% to 7.2% b

195 ostat produced a significant delay in median TTE: 16 hours (CI, 7-22) for placebo and 20 hours (CI, 1

196 Placebo median TTE was 98 hours with 95% confidence interval (CI) of 71

197 of low magnitude (<10%) except for mediocre TTE imaging or flail leaflets (both p < 0.001).

198 Most TTEs ordered in pediatric cardiology clinics were for in

199 accuracy was slightly higher using multiple TTE views (accuracy, 82%) than with only apical 4-chambe

200 nce of IE in 19% of patients with a negative TTE and 21% of patients with an indeterminate TTE.

201 E) was performed in patients with a negative TTE and a rapid rise of phase I immunoglobulin G titers.

202 A normal TTE was based on normal cardiac structure and function d

203 ency of small LV, HFpEF features, and normal(TTE) was 8%, 16%, and 45%, respectively.

204 Compared with normal(TTE), patients with small LV had reduced LV filling, as

205 ies investigating the diagnostic accuracy of TTE for proximal aortic dissection.

206 y sought to determine the appropriateness of TTE as currently performed in pediatric cardiology clini

207 d-Altman analysis indicated positive bias of TTE GLS compared with PET MPI longitudinal strain at str

208 ine estimates of morbidity from TEE, cost of TTE, cost of hospital admission for cardioversion and ut

209 analysis was used to estimate the effect of TTE measures on all-cause mortality.

210 LCA of TTE parameters identified four cardiovascular subphenoty

211 Latent class analysis (LCA) of TTE/hemodynamic parameters was performed in 801 patients

212 However, an important limitation of TTE is the difficulty obtaining interpretable images due

213 both sensitivity and specificity measures of TTE, TCD, or both compared to the gold standard of TEE.

214 n timely surveillance and overutilization of TTE in valvular disease provides a model to study variat

215 The sensitivity of TTE for detecting IE was 32%, and the specificity was 10

216 tic yield of TCD appears to outweigh that of TTE.

217 study identified differences in the yield of TTE based on patient age and most common indications rat

218 tric cardiology clinics, diagnostic yield of TTE for various AUC indications, and any gaps in the AUC

219 ith 20% of providers deemed overutilizers of TTEs and 25% underutilizers.

220 nically relevant structural abnormalities on TTE.

221 Mean aortic valve area on TTE was 0.79+/-0.21 cm(2), while mean AVCa score, volume

222 ate ATTR-CM from age/sex-matched controls on TTE videos (AI-Echo) and ECG images (AI-ECG) were deploy

223 0001) and increased left ventricular mass on TTE (adjusted odds ratio, 1.04 per mm Hg [95% CI, 1.01-1

224 ed with corresponding parameters measured on TTE.

225 o sports participation risk were observed on TTE in 11 of 510 participants (prevalence, 2.2%).

226 from patients undergoing initial outpatient TTE in 6 centers.

227 based educational intervention on outpatient TTE ordering by cardiologists and primary care providers

228 ional intervention on ordering of outpatient TTEs by attending academic cardiologists.

229 designed to reduce the number of outpatient TTEs that were deemed to be rarely appropriate by publis

230 intervention aimed at reducing rA outpatient TTEs.

231 Overall, TTE was similar between groups.

232 ergoing intraoperative TEE and postoperative TTE had preoperative characteristics similar to the over

233 On postoperative TTE, 40% () continued to have at least moderate MR (3 to

234 n intermediate or high clinical probability, TTE should be the diagnostic procedure of choice.

235 a collection of Type III effector proteins (TTEs) directly into the plant cell that function to over

236 e was a significantly lower proportion of rA TTEs in the intervention versus the control group (8.6%

237 tional intervention reduced the number of rA TTEs ordered by attending physicians in a variety of amb

238 The mean proportion of rA TTEs was significantly lower in the intervention versus

239 ary outcome measure was the proportion of rA TTEs.

240 After reperfusion, TTE was performed and hearts were collected for infarct

241 33%) and diagnosed only upon TEE or a second TTE in 7 (10%).

242 A second TTE was performed within 24+/-6 hours for a subset of do

243 LV ejection fraction was >50% on the second TTE.

244 1), whereas females were more likely to show TTE abnormalities like concentric LVH (40.8% versus 13.5

245 he PME image results when obtaining standard TTE images.

246 50%) during donor management on a subsequent TTE.

247 Systematic TTE in acute Q fever patients offers a unique opportunit

248 was higher (P=0.001) between CMR (0.99) than TTE readers (0.89).

249 tant volume (RVol) is more reproducible than TTE.

250 Diagnostic accuracy was higher for TEE than TTE for all end points (p < 0.001), but the difference w

251 ng routinely collected clinical data and the TTE framework.

252 es low impedance (2.7 Omega cm(-)(2)) at the TTE/H(2)O interface and enabling 2,000 cycles of prelith

253 For the TTE, we designated eight 6-month target trial enrollment

254 In the TTE for MG onset, the incidence rates (per 100,000 perso

255 There was no difference in the TTE ordering volume between the intervention and control

256 erived from TTE cells and the progeny of the TTE lineage did not survive beyond 200 days.

257 otor cortex for 20-min before performing the TTE test.

258 Beyond the global trends, we show that the TTEs and BRTs may vary substantially among ecosystem typ

259 These TTE indices were more important at predicting outcome th

260 A total of 493 (13%) of these TTEs showed LV dysfunction.

261 were performed in three conditions--TTE TMD, TTE 2D and TEE.

262 and whether THE is a valuable alternative to TTE regarding oncological doctrine and overall survival.

263 Alternatives to TTE have been proposed because of the reportedly high ra

264 (LR- = 0.04, 95% CI = 0.02-0.08) compared to TTE (LR- = 0.55, 95% CI = 0.42-0.72; p < 0.001).

265 (mean difference: -4.9+/-10%) as compared to TTE (P<0.01).

266 more sensitive but less specific compared to TTE for the detection of PFO in patients with cryptogeni

267 (AUC = 0.98, 95% CI = 0.97-0.99) compared to TTE studies (AUC = 0.86, 95% CI = 0.82-0.89).

268 nal prognostic stratification as compared to TTE, which may have direct impact on the indication of i

269 nce in the prediction of MACE as compared to TTE-LVEF resulting in net reclassification improvement o

270 etic resonance-modelled PCWP was superior to TTE in classifying patients as normal or raised filling

271 tive patients undergoing both transthoracic (TTE) echocardiography and transesophageal (TEE) echocard

272 ute (TEE) in 22% and in 9% by transthoracic (TTE) testing.

273 erval (CI) of 71 to 142 compared to Triostat TTE at 55 hours with CI of 44 to 92.

274 atients were included, of whom 142 underwent TTE before first endomyocardial biopsy.

275 161 underwent TTE, with an in-hospital mortality of 0.6%, 24%-pneumoni

276 patients included in the analysis underwent TTE before their procedure.

277 All patients underwent TTE and CMR, and left ventricle end-diastolic volume, le

278 andard deviation]; 63% female) who underwent TTE and cardiac MRI within a 6-month interval between 20

279 Among patients with COVID-19 who underwent TTE, cardiac structural abnormalities were present in ne

280 smoking association with quantity of urinary TTE.

281 nderwent a tricuspid valve surgery and using TTE (A4C) in 66 healthy volunteers.

282 orrelation was similar for CMR (0.94) versus TTE readers (0.90 for the proximal isovelocity surface a

283 ith anticardiolipin antibodies >60 GPLU when TTE is inconclusive or negative.

284 tients with an intermediate probability when TTE either does not yield an adequate study or indicates

285 with prosthetic valves and in those in whom TTE indicated an intermediate probability; these constit

286 ients who have prosthetic valves and in whom TTE is either technically inadequate or indicates an int

287 velocities, and gradients in agreement with TTE.

288 d severe AVS and were in good agreement with TTE.

289 ed endpoint compared with LVMI assessed with TTE (AIC, 127 vs 131).

290 0.951 and 0.912, respectively) compared with TTE (intraclass correlation coefficient, 0.940 and 0.871

291 quantification (r = 0.83), as compared with TTE (r = 0.68).

292 nuous LVEF differed 5% or less compared with TTE LVEF in 38.0% (309 of 813) of test data set studies,

293 E) of 8.5% (95% CI, 8.1%-9.0%) compared with TTE LVEF.

294 Compared with TTE, CMR has lower intraobserver and interobserver varia

295 Saline contrast with TTE using native tissue harmonics or transmitral pulsed

296 ivariable adjustment, myocardial injury with TTE abnormalities was associated with higher risk of dea

297 For those with TTE-LVH, treatment with antihypertensives may reduce the

298 del, TEE-guided early cardioversion, without TTE, is a reasonable cost-saving alternative to conventi

299 rdial injury, with myocardial injury without TTE abnormalities, and with myocardial injury and TTE ab

300 k of death but not myocardial injury without TTE abnormalities.